5 Takeaways From FDA's Unique Device ID Rule

Law360, New York (September 27, 2013, 5:53 PM ET) -- Medical device manufacturers are celebrating after scoring major concessions in the U.S. Food and Drug Administration's final rule this month on unique device identification, with experts describing surprising policy reversals that will strengthen tracking while not proving terribly burdensome.

"It's really a favorable rule," said Steven Niedelman of King & Spalding LLP. "It will provide just a much better landscape on post-market activity."

Here, attorneys tell Law360 their top five takeaways from a hard-fought regulation expected to encourage tidier recalls, reduce counterfeiting and enable better tracking...
To view the full article, take a free trial now.
Try Law360 for free for seven days
Already a subscriber? Click here to login

Already have access?

  1. Forgot your password?
  2. Sign In

Get instant access to the one-stop news source for business lawyers